Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%


Sezer A., Gogishvili M., Bentsion D., KILIÇKAP S., Lowczak A., GÜMÜŞ M. , ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 14 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1016/j.jtho.2019.08.1345
  • Title of Journal : JOURNAL OF THORACIC ONCOLOGY